ALTERED T-CELL ACTIVATION IN AUTOIMMUNE ARTHRITIS
ALTERED T-CELL ACTIVATION IN AUTOIMMUNE ARTHRITIS
批准号:
6895963
负责人:
JIAN ZHANG
金额:
$11.36万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-01 至 2009-02-28
关键词:
CD95 moleculeT lymphocyteapoptosisautoimmune disorderbiological signal transductioncell cyclecell deathcell growth regulationcell proliferationclinical researchcysteine endopeptidasesdisease /disorder modelenzyme activitygene expressiongenetically modified animalshelper T lymphocytehuman tissueimmunogeneticsinterleukin 4laboratory mouseleukocyte activation /transformationmolecular pathologyprotein degradationproteoglycanrheumatoid arthritis
中文摘要
过度刺激的T细胞活化诱导的细胞死亡(AICD)被认为是体内稳态和预防自身免疫的重要机制。通过T细胞抗原受体(TCR)反复刺激T细胞,诱导T细胞表面Fas和Fas配体(FasL)的共表达,Fas和FasL的相互作用导致T细胞的“自杀”或“自残”。蛋白多糖(PG)诱导的关节炎(PGIA)是一种用PG软骨系统免疫小鼠而形成的新型自身免疫性小鼠模型。在这个模型中,外周CD4+T细胞在体外对TCR刺激的异常增殖是
与关节炎小鼠低水平的AICD和高比率的干扰素(IFN)-γ和白介素4(IL-4)有关。PGIA小鼠的AICD缺陷和CD4+T细胞的过度增殖可能归因于未能诱导细胞Fas相关死亡结构域(FADD)样的IL-1β转换酶(FLICE)抑制蛋白(c-FLIP)降解。与野生型(Wt)BALB/c小鼠相比,IL-4缺陷(IL-4-/-)小鼠的PGIA发生率和严重程度增加,而给BALB/c小鼠注射IL-4可显著减少疾病。此外,PG诱导的IL-4-/-CD4+T细胞不能发生凋亡。基于这些观察结果,我们推测,IL-4的丢失导致c-flip降解失败,进而导致AICD缺陷和周围自身反应性Th1型细胞的过度增殖,从而导致PGIA的发生。为了证实我们的假设,我们提出了三个
具体目标:(1)我们将确定IL-4的丢失是否以及如何导致在IL-4-/-PGIA小鼠体内CD4+T细胞的积聚;(2)我们将研究c-flip是否调节IL-4-/-PGIA小鼠致关节炎的CD4+T细胞的过度增殖和缺陷AICD;以及(3)我们将确定IL-4是否通过调节细胞周期进程来调节自身反应性T细胞对AICD的易感性,并探讨IL-4是否通过控制c-fllip的表达来调节细胞周期进程。这些拟议研究产生的信息将增强我们对IL-4生物学功能的理解,并将有助于开发治疗自身免疫性关节炎的新方法。
英文摘要
Activation-induced cell death (AICD) of over-stimulated T cells has been proposed to be an important mechanism in homeostasis and the prevention of autoimmunity. Repeated stimulation of T cells through T cell antigen receptor (TCR) induces co-expression of Fas and Fas ligand (FasL) on the surface of T cells, and the Fas-FasL interaction leads to the "suicide" or "fratricide" of T cells. Proteoglycan (PG)-induced arthritis (PGIA) is a novel autoimmune murine model induced by systemic immunization of mice with cartilage PG. In this model, an aberrant proliferation of peripheral CD4+ T cells in vitro in response to TCR stimulation was
associated with low levels of AICD and a high ratio of interferon (IFN)-gamma to interleukin (IL)-4 in arthritic mice. The defective AICD and hyper-proliferation of CD4+ T cells in mice with PGIA may be ascribed to failure of inducing degradation of cellular Fas-associated death domain (FADD)-like IL-1beta-converting enzyme (FLICE)-inhibitory protein (c-FLIP). The incidence and severity of PGIA is augmented in IL-4-deficient (IL-4-/-) mice in comparison to wild-type (Wt) BALB/c mice, whereas administration of IL-4 to BALB/c mice greatly reduces disease. Moreover, PG-primed IL-4-/- CD4 + T cells fail to undergo apoptosis. Based upon these observations, we hypothesize that loss of IL-4 leads to a failure of inducing c-FLIP degradation which in turn results in defective AICD and hyperproliferation of autoreactive Th1-type cells in the periphery, thus leading to the development of PGIA. To confirm our hypothesis, we propose three
specific aims: (1) We will define whether and how loss of IL-4 results in accumulation of CD4+ T cells in IL-4-/- mice with PGIA in vivo; (2) We will investigate whether c-FLIP regulates hyper-proliferation and defective AICD of arthritogenic CD4+ T cells in IL-4-/- mice with PGIA; and (3) We will determine whether IL-4 regulates the susceptibility of autoreactive T cells to AICD by adjusting cell cycle progression, and investigate whether IL-4 regulates cell cycle progression through controlling c-FLIP expression. The information generated by the proposed studies will enhance our understanding of the biological function of IL-4 and will shed light on the development of novel therapeutic approaches to autoimmune arthritis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Protein Ubiquitination in Sepsis
-
批准号:9551775
-
项目类别:
-
资助金额:$28.74万
-
财政年份:2017
-
负责人:JIAN ZHANG
-
依托单位:
NEDD4 IN T HELPER CELL DEVELOPMENT AND AUTOIMMUNITY
-
批准号:9547050
-
项目类别:
-
资助金额:$51.41万
-
财政年份:2017
-
负责人:JIAN ZHANG
-
依托单位:
Regulation of Innate Immune System Sensing of C. albicans Infection
-
批准号:9262609
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2016
-
负责人:JIAN ZHANG
-
依托单位:
Role of Protein Ubiquitination in Sepsis
-
批准号:9303271
-
项目类别:
-
资助金额:$5.27万
-
财政年份:2016
-
负责人:JIAN ZHANG
-
依托单位:
Role of Protein Ubiquitination in Sepsis
-
批准号:9175444
-
项目类别:
-
资助金额:$34.01万
-
财政年份:2016
-
负责人:JIAN ZHANG
-
依托单位:
SBIR TOPIC321:CHEMICALLY DEFINED GLYCAN LIBRARIES FOR REFERENCE STANDARDS AND GLY
-
批准号:8758458
-
项目类别:
-
资助金额:$29.9万
-
财政年份:2013
-
负责人:JIAN ZHANG
-
依托单位:
Cbl-b in T Cell Activation and Autoimmunity
-
批准号:8616842
-
项目类别:
-
资助金额:$16.34万
-
财政年份:2013
-
负责人:JIAN ZHANG
-
依托单位:
Cbl-b in T Cell Activation and Autoimmunity
-
批准号:8493776
-
项目类别:
-
资助金额:$35.71万
-
财政年份:2013
-
负责人:JIAN ZHANG
-
依托单位:
STEADY-STATE FREE PRECESSION DIFFUSION IMAGING USING 3D ROTATING SPIRALS
-
批准号:8362916
-
项目类别:
-
资助金额:$1.95万
-
财政年份:2011
-
负责人:JIAN ZHANG
-
依托单位:
MAJOR INSTUMENTATION CORE
-
批准号:8357084
-
项目类别:
-
资助金额:$54.58万
-
财政年份:2011
-
负责人:JIAN ZHANG
-
依托单位:
MAJOR INSTUMENTATION CORE
-
批准号:8166222
-
项目类别:
-
资助金额:$66.33万
-
财政年份:2010
-
负责人:JIAN ZHANG
-
依托单位:
Measurement of CCR5 and CCL3L1 on Single Cell by Fluorescent Metal Nanoparticle
-
批准号:7740301
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2009
-
负责人:JIAN ZHANG
-
依托单位:
Measurement of CCR5 and CCL3L1 on Single Cell by Fluorescent Metal Nanoparticle
-
批准号:7904766
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2009
-
负责人:JIAN ZHANG
-
依托单位:
ALTERED T-CELL ACTIVATION IN AUTOIMMUNE ARTHRITIS
-
批准号:7393777
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2007
-
负责人:JIAN ZHANG
-
依托单位:
A Novel Protection Device for Shock Wave Lithotripter
-
批准号:6993066
-
项目类别:
-
资助金额:$9.11万
-
财政年份:2005
-
负责人:JIAN ZHANG
-
依托单位:
Cbl-b in T Cell Activation and Autoimmunity
-
批准号:7103405
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2004
-
负责人:JIAN ZHANG
-
依托单位:
Cbl-b in T Cell Activation and Autoimmunity
-
批准号:7436128
-
项目类别:
-
资助金额:$29.01万
-
财政年份:2004
-
负责人:JIAN ZHANG
-
依托单位:
Cbl-b in T Cell Activation and Autoimmunity
-
批准号:6821748
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2004
-
负责人:JIAN ZHANG
-
依托单位:
Cbl-b in T Cell Activation and Autoimmunity
-
批准号:7241548
-
项目类别:
-
资助金额:$29.61万
-
财政年份:2004
-
负责人:JIAN ZHANG
-
依托单位:
Cbl-b in T Cell Activation and Autoimmunity
-
批准号:6952385
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2004
-
负责人:JIAN ZHANG
-
依托单位:
海外基金